Page 172 - Orange Book Cumulative Supplement 10 October 2012

A - 35
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
OXYMORPHONE HYDROCHLORIDE - OPANA ER
N201655 006 7851482 Jul 10, 2029 DS
8114383 Aug 08, 2024 DP
8192722 Sep 15, 2025 DP
>A> 8309060 Nov 20, 2023 DP
>A> 8309122 Feb 04, 2023 DP
OXYMORPHONE HYDROCHLORIDE - OPANA ER
N201655 007 7851482 Jul 10, 2029 DS
8114383 Aug 08, 2024 DP
8192722 Sep 15, 2025 DP
>A> 8309060 Nov 20, 2023 DP
>A> 8309112 Feb 04, 2023 DP
PACLITAXEL - ABRAXANE
N021660 001 >A> 5439686 Feb 22, 2013 DP U-1290 >A> I-658 Oct 11, 2015
>A> 5439686 Feb 22, 2013 DP U-1092
>A> 5498421 Mar 12, 2013 DP U-1092
>A> 5498421 Mar 12, 2013 DP U-1290
>A> 5498421 Mar 12, 2013 DP U-634
>A> 6096331 Feb 22, 2013 DP U-1092
>A> 6096331 Feb 22, 2013 DP U-1290
>A> 6096331 Feb 22, 2013 DP U-633
>A> 6506405 Feb 22, 2013 DP U-633
>A> 6506405 Feb 22, 2013 DP U-1092
>A> 6506405 Feb 22, 2013 DP U-1290
>A> 6537579 Feb 22, 2013 U-1290
>A> 6537579 Feb 22, 2013 U-632
>A> 6537579 Feb 22, 2013 U-1092
>A> 7820788 Mar 03, 2024 DP U-1092
>A> 7820788 Mar 03, 2024 DP U-1290
>A> 7923536 Dec 09, 2023 U-1117
>A> 7923536 Dec 09, 2023 U-1290
>A> 8034375 Aug 13, 2026 U-1290
>A> 8138229 Dec 09, 2023 DP U-1092
>A> 8138229 Dec 09, 2023 DP U-1290
>A> 8268348 Feb 21, 2026 U-1290
>A> RE41884 Aug 14, 2016 U-1290
>A> RE41884 Aug 14, 2016 U-1117
PALIPERIDONE PALMITATE - INVEGA SUSTENNA
N022264 001 >A> 5254556 Oct 15, 2013 DS DP U-543 M-119 Aug 29, 2015
>A> 5254556*PED Apr 15, 2014
PALIPERIDONE PALMITATE - INVEGA SUSTENNA
N022264 002 >A> 5254556 Oct 15, 2013 DS DP U-543 M-119 Aug 29, 2015
>A> 5254556*PED Apr 15, 2014
PALIPERIDONE PALMITATE - INVEGA SUSTENNA
N022264 003 >A> 5254556 Oct 15, 2013 DS DP U-543 M-119 Aug 29, 2015
>A> 5254556*PED Apr 15, 2014